Integration with Existing Technology is Biggest Barrier to Digitalization for Telco Operators
Over 70% of telcos would struggle to integrate digital channels Key concerns are short term…
Over 70% of telcos would struggle to integrate digital channels Key concerns are short term…
Customisable multifunction printer recognised for innovation and adding value to the most demanding workplaces across…
Leading legal outsource company, Bluebird Support Services, has chosen Zylpha (www.zylpha.com) software for its e-bundling…
Leading AI unicorn welcomes industry-recognised senior data scientist to its U.K. team LONDON, 16 March,…
The Company expects to completely self-fund all operations going forward LOS ANGELES, March 16, 2021…
MARSEILLE, France, March 16, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
Marseille, March 16, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN:…
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in…
Press Release 16 March 2021 Immunicum AB (publ) Announces Updated Executive Management Team After Business…
Intertrade Shipping AS har mandag 15. mars kjøpt 1.500.000 aksjer i Vistin Pharma ASA forNOK 23,60…
Anchiano shareholders approve all resolutions at shareholder meeting The merged company is expected to receive…
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) — We are advised by Avicanna Inc. that journalists and…
SUNFISH Part 2 study population includes broad range of ages and disease severities, representing a…
– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint…
Daix (France), March 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
– Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million –…
MIAMI, March 15, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ:LGVN) (“Longeveron” or the “Company”), a…
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a…
Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia Interim…
Agreement leverages Fulgent’s Next Generation Sequencing (“NGS”) capabilities for genomic sequencing to aid in ongoing…